MOGAD in South Wales: Diagnostic Evolution and Disease Epidemiology
This regional study provides updated prevalence and incidence rates for MOGAD since the introduction of 2023 diagnostic criteria in a stable south Wales, UK population.
Authors
- Emma Clare Tallantyre (ORCID: https://orcid.org/0000-0002-3760-6634)
- Ray Wynford‐Thomas
- Katharine Harding (ORCID: https://orcid.org/0000-0001-6299-5582)
- Owen Pearson (ORCID: https://orcid.org/0000-0002-2712-0200)
- Mark R. Woodhall (ORCID: https://orcid.org/0009-0008-5980-7462)
- Patrick Joseph Waters (ORCID: https://orcid.org/0000-0003-4142-2667)
- Gillian Ingram (ORCID: https://orcid.org/0000-0001-5898-9462)
- Johann te Water Naudé
- C. Wood (ORCID: https://orcid.org/0000-0003-4217-7720)
- Dr Neil Robertson
- Sophie Voase
Institutions
- Swansea Bay University Health Board (GB)
- Royal Gwent Hospital (GB)
- University Hospital of Wales (GB)
- University of Oxford (GB)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/ene.70502
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00